Connection
Mark Eckardt to Cyclin-Dependent Kinase Inhibitor p16
This is a "connection" page, showing publications Mark Eckardt has written about Cyclin-Dependent Kinase Inhibitor p16.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.031 |
|
|
|
-
Murakami T, Singh AS, Kiyuna T, Dry SM, Li Y, James AW, Igarashi K, Kawaguchi K, DeLong JC, Zhang Y, Hiroshima Y, Russell T, Eckardt MA, Yanagawa J, Federman N, Matsuyama R, Chishima T, Tanaka K, Bouvet M, Endo I, Eilber FC, Hoffman RM. Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget. 2016 Jul 26; 7(30):47556-47564.
Score: 0.031